• 03 Jun 26

Poolbeg Pharma: What US Payers Really Said

Poolbeg Pharma: What US Payers Really Said

Poolbeg Pharma PLC | POLB | 8.0 -0.40 (0.0%)

    • 46 views

 
Independent US payer research commissioned by Poolbeg Pharma (AIM: POLB) shows strong commercial backing for POLB 001 — a first-in-class preventative for cancer immunotherapy-induced CRS. Chris from Acumentis Global on what payers said, and what it means for the commercial opportunity ahead.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Vox Markets Weekly Wrap

Companies: SKLCTLSDGELCOIGPGBGTTGTATETEPORRTRCSASAIEYETETSHOEPXENW7LRBWAOMDCCPALMMPALPOLBATG

Poolbeg Pharma kicks off POLB001 Phase 2a trial with specialist partner

Companies: Poolbeg Pharma PLC

Poolbeg Pharma: Sites ready, data due this summer — and Big Pharma is starting to knock

Companies: Poolbeg Pharma PLC

Poolbeg Pharma announces "very positive" efficacy data for POLB 001

Companies: Poolbeg Pharma PLC

2026 Could Be a Defining Year for POLB 001 and Oral GLP-1

Companies: Poolbeg Pharma PLC

Poolbeg Pharma, Polarean Imaging, Seeing Machines, Chariot, Valereum, Vaultz Capital

Companies: Poolbeg Pharma PLC

© Research Tree 2026

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top